SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022
Full-year 2022 guidance of $46 million - $48 million, an increase of 46% - 52% over 2021 unaudited revenue of approximately $31.5 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3998 USD | 0.00% |
|
+3,819.61% | +1,210.82% |
05-08 | DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc.. | CI |
04-02 | SRAX, Inc. announced that it has received $0.075 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+1,210.82% | 11.65M | |
+3.38% | 17.43B | |
-4.11% | 11.94B | |
-10.88% | 10.99B | |
-3.80% | 10.05B | |
+0.93% | 4.24B | |
-2.99% | 3.29B | |
+13.83% | 3.15B | |
-28.56% | 3.08B | |
+3.79% | 2.77B |